Amgen Inc. (AMGN)
Company Info
US0311621009
031162100
Jun 17, 1983
Highlights
$146.28B
$10.98
24.21
0.91
$34.13B
$21.50B
$12.38B
$251.27 - $338.98
$315.35
2.71%
4.28
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Amgen Inc. (AMGN) returned 2.83% year-to-date (YTD) and -11.67% over the past 12 months. Over the past 10 years, AMGN returned 8.36% annually, underperforming the S&P 500 benchmark at 10.46%.
AMGN
2.83%
-5.53%
-16.95%
-11.67%
5.03%
8.36%
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of AMGN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 9.51% | 8.80% | 1.13% | -6.62% | -8.61% | 2.83% | |||||||
| 2024 | 9.11% | -12.18% | 3.83% | -3.65% | 12.44% | 2.16% | 6.41% | 1.11% | -3.48% | -0.64% | -10.94% | -7.86% | -6.77% |
| 2023 | -3.90% | -7.41% | 4.36% | -0.83% | -7.09% | 0.62% | 5.46% | 10.36% | 4.85% | -4.86% | 6.28% | 6.82% | 13.46% |
| 2022 | 0.96% | 0.56% | 6.77% | -3.57% | 10.98% | -5.23% | 1.71% | -2.15% | -6.20% | 19.94% | 6.67% | -8.30% | 20.43% |
| 2021 | 5.01% | -6.14% | 10.62% | -3.69% | -0.01% | 2.44% | -0.91% | -5.91% | -5.71% | -2.67% | -3.10% | 13.12% | 0.89% |
| 2020 | -10.38% | -6.90% | 1.50% | 18.00% | -3.33% | 2.68% | 3.74% | 4.23% | 0.33% | -14.64% | 3.05% | 3.55% | -1.99% |
| 2019 | -3.88% | 2.37% | -0.05% | -5.61% | -6.24% | 10.55% | 1.25% | 12.60% | -7.24% | 10.20% | 10.80% | 2.71% | 27.60% |
| 2018 | 6.99% | -0.48% | -7.23% | 2.35% | 3.74% | 2.77% | 6.48% | 2.35% | 3.74% | -7.00% | 8.77% | -6.52% | 15.23% |
| 2017 | 7.16% | 13.45% | -7.06% | -0.46% | -4.26% | 10.94% | 1.32% | 2.56% | 4.88% | -6.02% | 0.94% | -1.00% | 22.27% |
| 2016 | -5.91% | -6.19% | 5.38% | 5.58% | 0.44% | -3.67% | 13.07% | -0.57% | -1.91% | -15.38% | 2.74% | 1.49% | -7.57% |
| 2015 | -4.41% | 4.13% | 1.35% | -1.21% | -0.56% | -1.75% | 15.03% | -13.65% | -8.87% | 14.36% | 2.36% | 0.76% | 3.95% |
| 2014 | 4.27% | 4.79% | -0.55% | -9.40% | 4.36% | 2.05% | 7.62% | 9.94% | 0.77% | 15.46% | 2.32% | -3.64% | 42.33% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of AMGN is 28, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Amgen Inc. (AMGN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Amgen Inc. provided a 3.43% dividend yield over the last twelve months, with an annual payout of $9.13 per share. The company has been increasing its dividends for 13 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $9.13 | $9.00 | $8.52 | $7.76 | $7.04 | $6.40 | $5.80 | $5.28 | $4.60 | $4.00 | $3.16 | $2.44 |
Dividend yield | 3.43% | 3.45% | 2.96% | 2.95% | 3.13% | 2.78% | 2.41% | 2.71% | 2.65% | 2.74% | 1.95% | 1.53% |
Monthly Dividends
The table displays the monthly dividend distributions for Amgen Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $2.38 | $0.00 | $0.00 | $0.00 | $2.38 | |||||||
| 2024 | $0.00 | $2.25 | $0.00 | $0.00 | $2.25 | $0.00 | $0.00 | $2.25 | $0.00 | $0.00 | $2.25 | $0.00 | $9.00 |
| 2023 | $0.00 | $2.13 | $0.00 | $0.00 | $2.13 | $0.00 | $0.00 | $2.13 | $0.00 | $0.00 | $2.13 | $0.00 | $8.52 |
| 2022 | $0.00 | $1.94 | $0.00 | $0.00 | $1.94 | $0.00 | $0.00 | $1.94 | $0.00 | $0.00 | $1.94 | $0.00 | $7.76 |
| 2021 | $0.00 | $1.76 | $0.00 | $0.00 | $1.76 | $0.00 | $0.00 | $1.76 | $0.00 | $0.00 | $1.76 | $0.00 | $7.04 |
| 2020 | $0.00 | $1.60 | $0.00 | $0.00 | $1.60 | $0.00 | $0.00 | $1.60 | $0.00 | $0.00 | $1.60 | $0.00 | $6.40 |
| 2019 | $0.00 | $1.45 | $0.00 | $0.00 | $1.45 | $0.00 | $0.00 | $1.45 | $0.00 | $0.00 | $1.45 | $0.00 | $5.80 |
| 2018 | $0.00 | $1.32 | $0.00 | $0.00 | $1.32 | $0.00 | $0.00 | $1.32 | $0.00 | $0.00 | $1.32 | $0.00 | $5.28 |
| 2017 | $0.00 | $1.15 | $0.00 | $0.00 | $1.15 | $0.00 | $0.00 | $1.15 | $0.00 | $0.00 | $1.15 | $0.00 | $4.60 |
| 2016 | $0.00 | $1.00 | $0.00 | $0.00 | $1.00 | $0.00 | $0.00 | $1.00 | $0.00 | $0.00 | $1.00 | $0.00 | $4.00 |
| 2015 | $0.00 | $0.79 | $0.00 | $0.00 | $0.79 | $0.00 | $0.00 | $0.79 | $0.00 | $0.00 | $0.79 | $0.00 | $3.16 |
| 2014 | $0.61 | $0.00 | $0.00 | $0.61 | $0.00 | $0.00 | $0.61 | $0.00 | $0.00 | $0.61 | $0.00 | $2.44 |
Dividend Yield & Payout
Dividend Yield
Amgen Inc. has a dividend yield of 3.43%, which is quite average when compared to the overall market.
Payout Ratio
Amgen Inc. has a payout ratio of 44.61%, which is quite average when compared to the overall market. This suggests that Amgen Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Amgen Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Amgen Inc. was 78.02%, occurring on Nov 19, 1984. Recovery took 336 trading sessions.
The current Amgen Inc. drawdown is 19.93%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -78.02% | Jun 20, 1983 | 361 | Nov 19, 1984 | 336 | Mar 21, 1986 | 697 |
| -63.5% | Mar 18, 1987 | 155 | Oct 26, 1987 | 405 | Jun 2, 1989 | 560 |
| -60.17% | Jul 24, 2000 | 494 | Jul 15, 2002 | 760 | Jul 20, 2005 | 1254 |
| -59.49% | Dec 2, 1992 | 176 | Aug 12, 1993 | 470 | Jun 22, 1995 | 646 |
| -53.61% | Sep 20, 2005 | 628 | Mar 19, 2008 | 1119 | Aug 24, 2012 | 1747 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Amgen Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Amgen Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 15.0% positive surprise.
Valuation
The Valuation section provides an overview of how Amgen Inc. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for AMGN, comparing it with other companies in the Drug Manufacturers - General industry. Currently, AMGN has a P/E ratio of 24.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for AMGN compared to other companies in the Drug Manufacturers - General industry. AMGN currently has a PEG ratio of 0.9. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AMGN relative to other companies in the Drug Manufacturers - General industry. Currently, AMGN has a P/S ratio of 4.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for AMGN in comparison with other companies in the Drug Manufacturers - General industry. Currently, AMGN has a P/B value of 23.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |